NDA 040196 describes WARFARIN SODIUM, which is a drug marketed by
Amneal Pharms,
Aurobindo Pharma Usa,
Barr,
Chartwell Rx,
Invagen Pharms,
Ipca Labs Ltd,
Pliva,
Taro,
Usl Pharma,
Watson Labs, and
Zydus Pharms Usa, and is included in seventeen NDAs. It is available from
twenty-three suppliers. Additional details are available on the
WARFARIN SODIUM profile page.
The generic ingredient in WARFARIN SODIUM is
warfarin sodium. There are twenty-two
drug master file entries for this compound. Twenty-four
suppliers are listed for this compound. Additional details are available on the
warfarin sodium profile page.